Trials / Completed
CompletedNCT01353417
Non-interventional-study With Tacrolimus Sandoz© Capsules for Prophylaxis of Renal Graft Rejection
A Single-site, Prospective Non-interventional-study With Adport Sandoz© Capsules for Prophylaxis of Graft Rejection in Patients With Stable Kidney Function After Renal Allograft.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 102 (actual)
- Sponsor
- Sandoz · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This non-interventional study intends to collect epidemiological data in patients with stable kidney function after renal transplantation, who receive Tacrolimus Sandoz© according to the approved indication.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | In this observational study no study specific intervention is planned | Patients with stable kidney function who already receive Tacrolimus Sandoz© capsules before being included in this non-interventional study, are being observed for 6 months by their attending physicians. Routine medical treatment is provided. |
Timeline
- Start date
- 2011-04-01
- Primary completion
- 2015-08-31
- Completion
- 2015-08-31
- First posted
- 2011-05-13
- Last updated
- 2017-04-07
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT01353417. Inclusion in this directory is not an endorsement.